Product Overview: PLAROS CV 10

PLAROS CV 10 is a dual cardiovascular medication manufactured by Ajantha. Combining 10mg of Rosuvastatin and 75mg of Clopidogrel, this capsule is indicated for secondary prevention of atherothrombotic events. It is designed to manage lipid profiles and prevent platelet aggregation, reducing the risk of stroke and heart attack in high-risk patients.

Primary Indications

• Secondary prevention of myocardial infarction and ischemic stroke in patients with hypercholesterolemia.
• Management of mixed dyslipidemia and coronary artery disease (CAD).
• Maintenance therapy post-angioplasty and stenting.

Clinical Benefits

• Dual Protection: Rosuvastatin lowers LDL cholesterol, while Clopidogrel prevents arterial thrombosis.
• High Efficacy: Rosuvastatin offers superior lipid clearing at lower doses than older statins.
• Single-Dose Convenience: Combines two essential therapies in one capsule, promoting compliance.

Possible Side Effects

Common side effects may include:

• Indigestion, nausea, or mild abdominal pain.
• Increased bleeding tendencies, such as nosebleeds or easy bruising.
• Myalgia (muscle pain or stiffness). Seek immediate medical help if severe.

How to Take PLAROS CV 10

• Take one capsule daily, preferably with a meal to reduce stomach irritation.
• Swallow the capsule whole; do not open, chew, or split.
• Avoid alcohol to minimize the risk of liver strain and bleeding.

Mechanism of Action

PLAROS CV 10 works through two distinct mechanisms:

• Rosuvastatin: Inhibits HMG-CoA reductase, reducing cholesterol synthesis and clearing LDL from the blood.
• Clopidogrel: Blocks platelet P2Y12 ADP receptors, preventing platelet activation.

Safety Warnings

• Bleeding Risk: Avoid in patients with active peptic ulcers, hemophilia, or internal bleeding.
• Pregnancy & Nursing: Strictly contraindicated due to the risk of fetal harm.
• Liver Function: Contraindicated in patients with active liver disease.

Patient Advice

• Inform all healthcare providers (including dentists) that you are taking this medication.
• Report any black, tarry stools, vomiting of blood, or persistent muscle pain immediately.
• Adhere to a low-cholesterol diet and regular exercise.

Fact Box

Drug Interactions

• Proton Pump Inhibitors: May decrease Clopidogrel efficacy.
• NSAIDs (Ibuprofen): Increase the risk of gastrointestinal bleeding.
• Cyclosporine: Significantly increases Rosuvastatin exposure.

User Feedback

• Patients report excellent control of lipid profiles and clinical stability post-stenting.
• Cardiologists frequently recommend this dual combination for secondary stroke prevention.